Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy - Wikidata - wikimedia - TriplyDB

Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy

Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy

http://www.wikidata.org/entity/Q36078440

about

Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies Modifier genes and their effect on Duchenne muscular dystrophy 204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands Age at onset of first signs or symptoms predicts age at loss of ambulation in Duchenne and Becker Muscular Dystrophy: Data from the MD STARnet.Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy.Management of cardiac involvement in muscular dystrophies: paediatric versus adult forms Osteopontin, inflammation and myogenesis: influencing regeneration, fibrosis and size of skeletal muscle The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy.Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy Genetic Modifiers for Neuromuscular Diseases Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy.Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants.Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study.Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients.Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype.The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials.Comparative Genomics of X-linked Muscular Dystrophies: The Golden Retriever Model DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy.Circulating Biomarkers for Duchenne Muscular Dystrophy.Dystrophin induced cognitive impairment: mechanisms, models and therapeutic strategies Variations in Duchenne muscular dystrophy course in a multi-ethnic UK population: potential influence of socio-economic factors.Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery.Outside in: The matrix as a modifier of muscular dystrophy.Genetic modifiers of muscular dystrophy act on sarcolemmal resealing and recovery from injury.Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database.Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells.226th ENMC International Workshop:: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands.SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells.Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.Changes in Muscle Metabolism are Associated with Phenotypic Variability in Golden Retriever Muscular Dystrophy.

P2860

Q26795772-2B45B0C1-F4FA-44E0-AD94-C1B6CB53BC8B Q28083441-0BD8B7A3-71F2-4DB9-8B8A-AF08D6F595F2 Q28611318-0F6F6C8F-00EE-4124-99AC-7E4E8C3FF6DD Q31056857-D82F9FCD-C9AB-4E4B-BD6F-B4911D19D038 Q33635762-813AD45D-55DE-4F99-BCC5-32A312C2BEA3 Q33635766-4F0A779F-83F2-4E9E-93D4-ABA6080799CC Q33779868-C0786F66-6F1E-40C5-8240-AC9F28D2A84C Q34042850-0FE1C832-EA88-4EAB-9945-E539595617CE Q34152280-4AE50264-4E3E-4139-A70E-477D1E0D47CF Q34332718-3B4C7269-E91D-4AA8-83CC-018734D319A7 Q34424160-477329C2-E775-474C-A008-341DFBDFE07F Q35119976-343B6349-4310-4DF4-9270-5200CD773828 Q35495274-FCE6CD3E-F58F-4232-BB22-F85176872452 Q35826211-55EC306D-CF7A-463D-BC33-15CB2FDB5D52 Q36150125-731C654A-121C-438D-B5FC-90E1AF377187 Q36155677-DEA5ED61-803A-4C19-97A7-66C78868C230 Q36334428-0209ED0A-CF1D-4C20-9448-FACE5E17F2A6 Q36344905-FB674C89-22D4-4148-91E4-E3450AA2C13E Q36577433-8A0A0C07-FA2A-4365-94B3-37228A7A25A4 Q37148808-2E13A66E-535F-4C87-AD56-0A3DDB81A91A Q37158951-FB599134-5647-410C-95F6-F2573BAE9CB4 Q37298079-8F55E3F6-B2C5-4370-980A-7661237517A9 Q37396900-1B146B96-C78C-4DAF-B407-2837B073C7F9 Q37610530-EA2DF8A5-F82E-4DE9-A643-4FBC57F08EDE Q38541264-7CA18173-6BF5-4120-88C3-30F9810A4763 Q38783404-D62C7EF9-6D00-445B-A473-34C3D04732F3 Q38816248-35A448DF-0C9B-4E64-B6A8-F338E5F34EC1 Q39052032-1D9AB82D-624D-4FF8-A76C-2B219BFC314F Q44907195-CD01A175-6DAD-4464-94D2-A26E4A824708 Q45874288-ACB92D0B-DF98-4CEE-A548-3470D6C3D00C Q47153959-D3AA64A5-C427-46D9-97C6-5207AB3FAA58 Q48543939-F936FD9D-2B53-47BB-8B6F-93E09E58A2B5 Q50953438-7CBAF0F3-A14B-4E2A-8FA5-152FF2E3AA6B Q52372774-5475D0EA-82FC-409A-B680-8AEA91482681 Q54988224-267B0E78-70FE-46AE-B50E-EFF283F315A5

P2860

Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy

http://www.wikidata.org/entity/Q36078440

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy

@ast

Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy

@en

type

label

Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy

@ast

Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy

@en

prefLabel

Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy

@ast

Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy

@en

P1433

Q36078440-96E798B1-9D4F-4F74-8B64-0C922B5E322D

P1476

Q36078440-9EAD2A34-5029-4435-9429-61BEE8FAB361

P2093

Q36078440-0C54313D-5BA6-49E0-8E28-2FE9DB434036

Q36078440-10BA9907-F33D-4641-83E6-6635D6AEF69E

Q36078440-22762383-7FA6-41C9-A555-D02CCB429830

Q36078440-26C57DE7-3ECD-4312-86B8-D80861801578

Q36078440-2B06258C-2EC7-4614-8C2F-2CD0DB965505

Q36078440-31AC6D1B-12EB-4855-994C-FABCCA462880

Q36078440-32056F48-77EF-472D-A8EC-388CCB5D3969

Q36078440-3551AC4E-DA56-4353-A06C-63B2DB2858DB

Q36078440-3DDC14C8-BB42-4518-9AF3-310B91E3E6E1

Q36078440-3E17AB3A-B11D-43A7-A329-41234A5ED857

P2860

Q36078440-02441D28-F6F0-4B35-B1C0-6BCD0C4A5214

Q36078440-28DEA607-ECF0-4570-A0B7-CAC7BAD5EE1C

Q36078440-2FB43A7F-70C7-4B57-BA45-E8E46406E7E1

Q36078440-37B9FBBE-FDFE-4E52-B5E2-CD57C2AB8ADD

Q36078440-50892A6F-5395-49CA-A3DF-0A7A310725CA

Q36078440-A428AF77-2B6D-45DE-B322-3F2AC2AACE0D

Q36078440-E1BF0473-3D27-4A4D-A729-E9BBD030FBE7

Q36078440-E46BFFC1-DF27-43E1-8443-02648F552F27

P304

Q36078440-6BF8B347-D183-4975-97AE-3EAFA250EDF2

P31

Q36078440-DF57A0C0-092C-49F2-9B06-68AEDE9629B7

P356

Q36078440-FDA21660-9D4E-466C-9874-A7521E65B3A1

P407

Q36078440-33D25D10-60DD-455C-B9F0-8D9F5AB45C1C

P433

Q36078440-978DB9C8-9D8C-4B82-96B5-91585A58AD9A

P478

Q36078440-DF5A1571-7380-4431-B2DE-2ED97C3613BA

P50

Q36078440-002B2DC7-304D-474A-B165-9EED5CB15F3E

Q36078440-0CD2ACE2-322C-4647-8789-6C1274FE07E9

Q36078440-0E122F82-AE3F-4DEF-B849-A93989450CDC

Q36078440-270F1AEF-BAA2-46A2-A791-35F6C39A0752

Q36078440-560804E0-59E4-45F1-B268-D37058E2ABB7

Q36078440-7327C9E2-2929-4538-85A9-85ADE3EBB704

Q36078440-93DDEA22-A20E-4F43-AA47-7D26561E37F0

Q36078440-B092328E-B051-43F4-8F65-73D3B676AFCF

Q36078440-C86B224A-1F72-4D43-83F7-92A43299E5C5

Q36078440-C94CE5AF-B90E-4A1E-9D38-E18A514EB2AF

P577

Q36078440-40D92360-E5AD-481F-8891-79F577535CC2

P5875

Q36078440-18A22C39-2C22-4B30-96C3-2CC490E05923

P698

Q36078440-BA6ED5DD-3855-4EB9-A7BE-41EB72F52F92

P921

Q36078440-C1704F0B-16B9-434A-8392-FB0D0900439D

P932

Q36078440-10B4B5ED-1857-443C-993D-99224AAA9B02

P356

WNL.0B013E31825F04EA

P1433

P1476

Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy

@en

P2093

Adele D'Amico

http://www.w3.org/2001/XMLSchema#string

Alessandra Ferlini

http://www.w3.org/2001/XMLSchema#string

Andrea Barp

http://www.w3.org/2001/XMLSchema#string

Angela Berardinelli

http://www.w3.org/2001/XMLSchema#string

Antonella Taglia

http://www.w3.org/2001/XMLSchema#string

Carlo Minetti

http://www.w3.org/2001/XMLSchema#string

Claudio Bruno

http://www.w3.org/2001/XMLSchema#string

Elena Pegoraro

http://www.w3.org/2001/XMLSchema#string

Elisabetta Gazzerro

http://www.w3.org/2001/XMLSchema#string

Eric P Hoffman

http://www.w3.org/2001/XMLSchema#string

P2860

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy

Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta

Osteopontin and skeletal muscle myoblasts: association with muscle regeneration and regulation of myoblast function in vitro

Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease.

Reliability of the North Star Ambulatory Assessment in a multicentric setting.

The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.

Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.

North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy

P304

159-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E31825F04EA

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Magri

Corrado Angelini

Stefano C. Previtali

Roberta Battini

P577

2012-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228088537

http://www.w3.org/2001/XMLSchema#string

P698

22744661

http://www.w3.org/2001/XMLSchema#string

P921

P932

3390537

http://www.w3.org/2001/XMLSchema#string